MAPT and Alzheimer disease: Some studies pointed to high levels of p-tau in individuals with AD-associated dementia compared with controls, levels which reached aplateauabout 10 years before clinical diagnosis,44, 46, 47which indicates that p-tau analysis may be less efficient than Aß42 analysis with respect to the investigation of disease progression.